Despite that cannabis stocks have sold off lately, there are two companies that I like lot as long-term investments for Foolish readers. As the market for cannabis stocks as a whole has become as ...

Let's dive into two top Canadian pot stocks, and why these companies could have more upside than the market is granting right ...

Tilray's beverage business now generates $241 million annually, nearly matching its $249 million in cannabis revenue. Canopy Growth narrowed its adjusted EBITDA loss to 7.9 million Canadian dollars ...

Green Thumb Industries, valued at $2.4 billion, operates in the U.S. cannabis market and has declined nearly 80% from its peak, yet continues to generate consistent profits despite broader industry ...

The provision bans online, gas station, and corner store sales of intoxicating hemp products, including delta-8, starting in ...

Green Thumb Industries reported Q3 revenue above expectations and maintains positive tangible book value. Read why GTBIT ...

Haywood’s Neal Gilmer said Green Thumb’s diversified product portfolio and disciplined cost management continue to support stable performance across core markets ...

In the past three months, shares of Tilray Brands TLRY have skyrocketed 94.5%, significantly outperforming the industry’s 2.5% decline. Image Source: Zacks Investment Research TLRY stock has risen ...

Canopy Growth’s latest results showcased stronger execution and renewed momentum across key markets. Is CGC stock finally ...

Aurora Cannabis Inc. is rated a Buy with 40% upside in current levels and expects solid growth in medical cannabis sales.

Valued at a market cap of $2.4 billion, Green Thumb Industries (CNSX:GTII) is a cannabis stock that is down almost 80% from all-time highs. Green Thumb manufactures, distributes, markets, and sells ...